Pricing Log in Create free account

Champions Oncology, Inc. (CSBR) vs Tenaya Therapeutics, Inc. (TNYA)

Champions Oncology, Inc. and Tenaya Therapeutics, Inc. are both Biotechnology companies. Champions Oncology, Inc. and Tenaya Therapeutics, Inc. are of similar size ($72.0M and $66.3M). Tenaya Therapeutics, Inc. has the higher net margin (0.00% vs −1.87%) and the higher return on invested capital (0.00% vs −626.2%). Across the 13 metrics below, Tenaya Therapeutics, Inc. leads on 7 and Champions Oncology, Inc. on 6.

Valuation

Metric CSBR TNYA Biotechnology median
P/E n/m n/m 10.60
P/S 1.10 n/m 9.40
P/B 14.96 1.49 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 200.80 n/m 0.66
EV/Sales 1.03 n/m 9.02
Earnings yield (1.67%) (137.17%) (32.88%)
Free cash flow yield (9.16%) (67.13%) (23.13%)

Profitability

Metric CSBR TNYA Biotechnology median
Gross margin 49.82% 0.00% 68.51%
Operating margin (1.68%) 0.00% 0.00%
Net margin (1.87%) 0.00% 0.00%
Free cash flow margin (10.08%) 0.00% 0.00%
Return on equity (28.38%) (148.16%) (51.96%)
Return on assets (3.56%) (112.05%) (46.06%)
Return on invested capital (626.23%) 0.00% 0.00%

Growth

Metric CSBR TNYA Biotechnology median
Revenue growth (TTM) 6.65% — 6.76%
EPS growth (last fiscal year) (124.24%) 54.96% 29.88%
Revenue growth, 5-year CAGR 7.68% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CSBR TNYA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.03 3.78 4.97
Net debt to EBITDA (20.56) 1.19 1.01

Dividend

Metric CSBR TNYA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CSBR TNYA Biotechnology median
Market cap 66.26m 72.02m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack